iSOFT Wins Two Regional Contract Extensions in Spain

iSOFTiSOFT Spain has won two contracts worth a total of €1.35 million with the public healthcare services of Andalusia and the Balearic Islands, with both customers extending their current agreements with the company. The Andalusian healthcare service (SAS) has renewed its contract for maintenance at 16 hospitals for another year in a deal worth €750,000. In addition, the Balearic Islands healthcare service (IB-SALUT) has awarded iSOFT a €600,000 contract extension to roll out its e-prescription solution to all primary care centres and pharmacies in Mallorca and Menorca.

Andalusia
The contract extension with the SAS is for the support, development and preventative maintenance of a range of iSOFT applications at hospitals across Andalusia's regional healthcare service. The initial project was awarded in 2006 and this latest order brings the total value of the work to €2.25 million.

The contract covers 16 of the 28 hospitals operated by the SAS across the Andalusia region. Some hospitals have one iSOFT application while others have the full range. These include x‑HIS (patient management), e-HC (electronic patient record), x-GPC (clinical order management) and departmental solutions such as PAT-Win (pathology), x-UC (intensive care), x‑LOG (logistics), x-LAB (laboratory) and x-FARMA (pharmacy).

Antonio Castillo, iSOFT Spain’s Strategic Accounts Director, said: "This maintenance contract extension is very important for iSOFT and clearly demonstrates that we continue to provide a first-class service and innovative solutions for public hospitals in the Andalusia region."

Balearic Islands
The Balearic Islands healthcare service (IB-SALUT) has awarded iSOFT a €600,000 contract extension to roll out its e-prescription solution to all primary care centres and pharmacies in Mallorca and Menorca, following a successful, award-winning project in Ibiza and Formentera. The total value of this project is €1.7 million after iSOFT won an initial €1.1 million order in 2006.

The e-prescription solution eliminates paper and so saves time, avoids mistakes and improves the monitoring of treatment. It also provides prescribing rules, a recommended list of drugs and automation of payments.

Roll-out to the 43 primary care centres in Mallorca will be completed this month and in the five centres in Menorca by December. Ultimately, the solution will be installed at the 55 health centres and 411 pharmacies across the four Balearic Islands for a population of 1.2 million people.

The latest phase follows successful projects at seven primary care centres in Ibiza and Formentera. During the six-month pilot, the application was used for over 27,500 prescriptions out of nearly 34,500 prescriptions dispensed.

In March this year, the project won the Correo Farmacéutico magazine award for best technology initiative, having won in March of last year the ComputerWorld magazine award for its positive impact on the local population.

Antonio Castillo said: "We have worked very closely with IB-SALUT since 2004 in helping it develop an electronic patient record for primary care and improve services to the people of the Balearic Islands. We are the preferred supplier of primary care systems and our e-SIAP solution is installed at all IB-SALUT's primary care centres, so it is very gratifying to also participate in the e-prescription implementation, an innovative project led by IB-SALUT that will serve as model for other autonomous regions."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest specialist information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of over 3,500 healthcare IT experts around the globe.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the Company's website at www.ibahealth.com.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...